Submission of Annual report for the FY 2025-26

To, Date: 07.11.2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, 5th Floor, Plot No.CI1, Dalal Street, Fort, G-Block, 13andra-Kurla Complex, Mumbai 400 001. Bandra (E), Mumbai 400 051. BSE Scrip Code: 543298 NSE Scrip Code: VINEETLAB Dear Sir/ Madam, Sub: Submission of Annual report for the FY 2025-26 In compliance of Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) 2015, we are herewith submitting Annual Report of the Company. This is for the information and records of the Exchange, please. Yours faithfully, For Vineet Laboratories limited Kathulla Rajesh Kumar Director (DIN: 05349717) 10TH ANNUAL REPORT 2025–26 A Year of Turnaround and Recapitalisation INSIDE THIS REPORT Contents · About Vineet Laboratories 3 Who we are · FY 2025-26 at a Glance 4 Key performance highlights · Corporate Information 5 Board, committees & advisors 01 Notice of the 10th Annual General Meeting 6 10th Annual General Meeting 02 Directors' Report 20 For the Financial Year ended March 31, 2026 03 Report on Corporate Governance 35 In accordance with Regulation 34(3) read with Schedule V of SEBI (LODR) Regulations, 2015 04 Related Party Transactions 64 Form No. AOC-2 05 Particulars of Employees 66 Pursuant to Section 197(12) of the Companies Act, 2013 06 Management Discussion & Analysis 69 For the Financial Year ended March 31, 2026 07 Secretarial Audit Report 77 Form MR-3 08 Corporate Social Responsibility 80 Annual Report on CSR Activities for the Financial Year 2025-26 09 Independent Auditor's Report 84 On the Financial Statements for the year ended 31 March 2026 10 Financial Statements 94 Balance Sheet, P&L, Cash Flow, Equity & Notes 11 Material Accounting Policies 115 Notes to Financial Statements 10th Annual General Meeting Monday, 30th November, 2026 at 11.00 A.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) 10th Annual Report 2025-26 2 WHO WE ARE About Vineet Laboratories Incorporated in 2016 and listed on BSE Limited (Scrip Code: 543298) and the Na‐ tional Stock Exchange of India Limited (Symbol: VINEETLAB), Vineet Laboratories Limited is a Hyderabad-based manufacturer of advanced pharmaceutical inter‐ mediates, bulk drugs and fine/specialty chemicals. The Company's strength lies in multi-step synthetic chemistry, process development and scale-up, en‐ abling it to serve domestic and international pharmaceutical and personal-care customers with consistent quality. 2016 BSE · NSE 108 Hyderabad Year of incorporation Scrip 543298 · Symbol VIN‐ Permanent employees on Telangana, India EETLAB rolls Our Product Families The Company operates in a single reportable business segment, namely pharmaceutical intermediates, bulk drugs and fine chemicals. During FY 2025-26, the product portfolio was deliberately rationalised towards higher-value, better-mar‐ gin molecules and away from low-margin, commoditised lines. Specialty API Ophthalmic intermediates Personal care and intermediates specialty chemicals Dorzolamide and Brinzolamide Intermediates for anti-retrovirals derivatives used in anti-glaucoma Piroctone Olamine (anti-dandruff (Ritonavir and Lopinavir interme‐ therapies active), Avobenzone and other diates), anti-fungals UV filters such as Tinosorb S and (Voriconazole intermediates) and Ethylhexyl Triazone used in sun- anti-ulcer / specialty therapeutic care and dermatological formula‐ categories tions 10 th Monday, 30th November, 2026 · 11.00 A.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means ANNUAL GENERAL MEETING (“OAVM”) 10th Annual Report 2025-26 3 FINANCIAL HIGHLIGHTS FY 2025-26 at a Glance FY 2025-26 was a defining year for the Company — a year of turnaround and re‐ capitalisation. REVENUE FROM EBITDA NET PROFIT NET WORTH OPERATIONS ₹59.40 ₹8.49 ₹1.11 ₹45.60 Cr Cr Cr Cr FY 2024-25: ₹75.00 Cr Margin 14.29% · vs loss of vs net loss of ₹20.19 Cr +211.3% from ₹14.65 Cr ₹16.28 Cr DEBT-EQUITY CURRENT RATIO CASH & CASH EARNINGS PER SHARE EQUIVALENTS 0.99 1.47 ₹16.70 ₹1.00 x x Cr from 2.73x from 0.91x from ₹0.31 Cr from ₹(21.90) Turnaround in numbers FY 2024-25 FY 2025-26 (₹ crore) 80 75.00 59.40 45.60 20 14.65 8.49 1.11 -20 (16.28) (20.19) Revenuefromoperations EBITDA Profitaftertax Networth Fully subscribed Rights Issue ₹29.96 99,87,258 equity shares of ₹10 each at ₹30 per share. Paid-up equity share cap‐ ital increased from ₹9.22 crore (92,19,008 shares) to ₹19.21 crore (1,92,06,266 shares). 10th Annual Report 2025-26 4 COMPANY AT A GLANCE Corporate Information BOARD OF DIRECTORS Mr. Gaddam Venkata Ramana Director DIN 00031873 Mr. Satyanarayana Raju Bhupathiraju Executive Director DIN 02697880 Mr. Dilip Vishnu Acharekar Independent Director DIN 08849689 Mr. Ranga Raju Alluri Non-Executive Director DIN 07302447 Ms. Jasmin Kunal Tailor Non-Executive Director DIN 01750325 Mr. Premananda Reddy Vennapusa Independent Director DIN 09598868 Mr. Rajesh Kumar Kathulla Whole Time Director DIN 05349717 KEY MANAGERIAL PERSONNEL REGISTERED OFFICE Mr. Gaddam Venkata Ramana Sy. No. 11/A3, Saheb Nagar, Kurdu Vill, Managing Director Chintal Kunta, Eshwaramma Nilayam, L B Nagar, Hyderabad, Telangana, 500074 Mr. Ramesh Kumar Bandari Company Secretary & Compliance Officer Phone: +91- 040-24128833 E-Mail: cs@vineetlabs.co.in Website: www.vineetlabs.co.in CIN: L24304TG2016PLC112888 STATUTORY AUDITORS INTERNAL AUDITOR M/s. NSVR & Associates LLP, M/s. V D P & Co, Chartered Accountants Chartered Accountants House No.1-89/1/42, 3rd Floor, Plot No. 41 & 43, Sri Ram Nagar Flat no.404, Nirmal Tower, Dwarakapuri, Punjagutta, Hyderabad, Colony, Kavuri Hills, Madhapur, Hyderabad, Telangana - Telangana 500082. 500081. COST AUDITOR Ph: 040 - 23391164, E-mail: info@nsvr.in M/s. KJU & Associates, Cost Accountants, Hyderabad SECRETARIAL AUDITOR REGISTRAR & SHARE TRANSFER AGENTS M/s P. S. Rao & Associates M/s. Venture Capital and Corporate Investments Private Practicing Company Secretary Limited 6-3-347-22/2, Flat-10, 4th Floor, Iswarya Nilayam, Dwarakapuri “AURUM”, 5th Floor, Plot No.57, Jayabheri Enclave Phase – II, Colony, Punjagutta, Hyderabad, Telangana 500082. Gachibowli, Hyderabad – 500032 Phone Number: 040-23818475, 040-23818476 BANKERS Website: https://www.vccipl.com/ HDFC Bank Limited Email: online@vccipl.com BOARD COMMITTEES Audit Committee Nomination & Remuneration Stakeholders Relationship Corporate Social Committee Committee Responsibility Committee Ms. Jasmin Kunal Tailor – Chairperson Ms. Jasmin Kunal Tailor – Ms. Jasmin Kunal Tailor – Ms. Jasmin Kunal Tailor – Mr. Dilip Vishnu Acharekar – Chairperson Chairperson Chairperson Member Mr. Dilip Vishnu Acharekar – Mr. Dilip Vishnu Acharekar – Mr. Dilip Vishnu Acharekar – Mr. Satyanarayana Raju Member Member Member Bhupathiraju – Member Mr. Alluri Ranga Raju – Member Mr. Alluri Ranga Raju – Member Mr. Alluri Ranga Raju – Member LISTED AT ISIN (NSDL & CDSL) WEBSITE INVESTOR E-MAIL ID BSE Limited INE505Y01010 https://vineetlabs.co.in cs@vineetlabs.co.in National Stock Exchange of India Limited 10th Annual Report 2025-26 5 Notice of the 10th Annual General Meeting Monday, 30th November, 2026 · 11.00 A.M. (IST) · through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) Notice is hereby given that the 10th Annual General Meeting of members of M/s. Vineet Laboratories Limited will be held on Monday, the 30th day of November, 2026 at 11.00 A.M. (IST) through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) to transact the following business: ORDINARY BUSINESS: 1. To receive, consider and adopt the Standalone Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date together with the Notes attached thereto, along with the Report of Auditors and Directors thereon. 2. To appoint a director in place of Mr. Satyanarayana Raju Bhupathiraju (DIN: 02697880) who retires by rotation and being eligible, offers himself for re-appointment. 3. [Showing first 8,000 characters — download PDF for full document]